I. Lihrmann et al., FROG DIAZEPAM-BINDING INHIBITOR - PEPTIDE SEQUENCE, CDNA CLONING, ANDEXPRESSION IN THE BRAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 91(15), 1994, pp. 6899-6903
Three peptides derived from diazepam-binding inhibitor (DBI) were isol
ated in pure form from the brain of the frog Rana ridibunda. The prima
ry structures of these peptides showed that they correspond to mammali
an DBI-(1-39), DBI-(58-87), and DBI-(70-87). A set of degenerate prime
rs, whose design was based on the amino acid sequence data, was used t
o screen a frog brain cDNA library. The cloned cDNA encodes an 87-amin
o acid polypeptide, which exhibits 68% similarity with porcine and bov
ine DBI. Frog DBI contains two paired basic amino acids (Lys-Lys) at p
ositions 14-15 and 62-63 and a single cysteine within the biologically
active region of the molecule. Northern blot analysis showed that DBI
mRNA is expressed at a high level in the brain but is virtually absen
t in peripheral tissues. The distribution of DBI mRNA and DBI-like imm
unoreactivity in the frog brain was studied by in situ hybridization a
nd immunocytochemistry. Both approaches revealed that the DBI gene is
expressed in ependymal cells and circumventricular organs lining the v
entricular cavity. Since amphibia diverged from mammals at least 250 m
illion years ago, the data show that evolutionary pressure has acted t
o conserve the structure of DBI in the vertebrate phylum. The distribu
tion of both DBI mRNA and DBI-like immunoreactivity indicates that DBI
is selectively expressed in glial cells.